下個月改名了,叫Zevra查看全文
黄野仁2023-01-23 21:11
$KemPharm(KMPH)$
kempharm上週兩個消息:T博士離開管理層,重新回到科研前線。以他的業餘管理水平,被視作好消息
其次是Az藥上週腳本超過5400,上市以來新高,開始銷路有點起色查看全文
黄野仁2022-10-24 13:28
$KemPharm(KMPH)$
看看对手AYTU旗下两只多动症药物最新脚本/周:
AYTU Adzenys,week ending/scripts
10/14------------4.880
AYTU Cotempla,week ending/scripts
10/14------------2,740
他的季报是这两个利润:ADHD (Adzenys XR-ODT and Cotempla XR-ODT) net revenue...查看全文
黄野仁2022-05-16 10:16
$KemPharm(KMPH)$ $Orphazyme(ORPH)$
T博士對自己這麽自信?Azstarys銷售還沒上軌道又1700萬買個丹麦生物技术公司 Orphazyme ApS的Arimoclomol?
一直以爲kmph會給別人壓價收購,想不到是他趁生科低潮收購別人。
不過看歷史,T博士這家夥對FDA批准很有心得,他的Apadaz,Azstarys都順利...查看全文
Spica2022-04-20 21:15
回复@黄野仁: SDX I期试验开始给药,股价涨8% $KemPharm(KMPH)$ 网页链接//@黄野仁:回复@Spica:是的,爬波一般般,這麼好的藥。五月份會進入全美最大的unh聯合健康保險,到時再看數據查看全文
$KemPharm(KMPH)$ 8-K - Current report Filed: 2019-04-11 AccNo: 0001437749-19-007005 Size: 2 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$KemPharm(KMPH)$ CT ORDER - Confidential treatment order Filed: 2019-03-22 AccNo: 9999999997-19-001876 Size: 91 KB 网页链接
$KemPharm(KMPH)$ DEF 14A - Other definitive proxy statements Filed: 2019-03-15 AccNo: 0001193125-19-075693 Size: 433 KB 网页链接
$KemPharm(KMPH)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-03-15 AccNo: 0001193125-19-075701 Size: 106 KB 网页链接
$KemPharm(KMPH)$ 8-K - Current report Filed: 2019-03-13 AccNo: 0001437749-19-004718 Size: 1 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$KemPharm(KMPH)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-01 AccNo: 0001437749-19-003789 Size: 9 MB 网页链接
$KemPharm(KMPH)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-03-01 AccNo: 0001193125-19-061172 Size: 478 KB 网页链接
$KemPharm(KMPH)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-03-01 AccNo: 0001193125-19-061180 Size: 15 KB 网页链接
$KemPharm(KMPH)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-03-01 AccNo: 0001437749-19-003803 Size: 78 KB 网页链接
$KemPharm(KMPH)$ 8-K - Current report Filed: 2019-02-28 AccNo: 0001437749-19-003641 Size: 3 MBItem 1.01: Entry into a Material Definitive AgreementItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接